Brigham and Women's Hospital: Thromboembolism trials
The registry lists 10 Thromboembolism studies with Brigham and Women's Hospital as lead sponsor. 0 are open to participants now and 0 have results posted.
No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims DataCompletedNCT05264168
- Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims DataCompletedNCT04736719
- Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims DataCompletedNCT04735523
- COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic ComplicationsCompletedNCT04535128
- Improving Safety of Diagnosis and Therapy in the Inpatient SettingCompletedNCT04393909Not applicable
- Patient Safety Learning Laboratory: Making Acute Care More Patient-CenteredCompletedNCT02969343Not applicable
- Discharge ALERT: Quality Improvement InitiativeCompletedNCT00853463Not applicable
- Retrospective Study to Review Patients at Risk for VTE at Hospital DischargeCompletedNCT00604370
- Epidemiology of Venous ThromboembolismCompletedNCT00456196
- Epidemiology of Venous ThromboembolismCompletedNCT00041457